TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from PainChek Ltd ( (AU:PCK) ).
PainChek Ltd has announced the issuance of 3,361,525 fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX) under the code PCK. This move is part of the company’s strategy to enhance its market presence and provide liquidity to its shareholders, potentially impacting its operational capabilities and market positioning positively.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, focusing on developing innovative pain assessment solutions. The company’s primary product is a smartphone-based application that uses artificial intelligence to assess and score pain levels in patients who cannot communicate effectively, such as those with dementia.
Average Trading Volume: 3,839,538
Technical Sentiment Signal: Buy
Current Market Cap: A$171.4M
See more insights into PCK stock on TipRanks’ Stock Analysis page.